Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; Activation following aggregation of FcεRI or FcγRI

Leukemia Research

Volumn 27, Issue 8, 2003, Pages 677-682

  Kirshenbaum, Arnold S ^a   Akin, Cem ^a   Wu, Yalin ^a   Rottem, Menachem ^a   Goff, Julie P ^b   Beaven, Michael A ^c   Rao, V Koneti ^d   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Fc RI receptors; Fc RI; Mast cells; SCF

Indexed keywords

ANTIGEN; BETA N ACETYLHEXOSAMINIDASE; CD103 ANTIGEN; CD14 ANTIGEN; CD184 ANTIGEN; CD195 ANTIGEN; CD22 ANTIGEN; CD31 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; CD71 ANTIGEN; CD9 ANTIGEN; CHYMASE; FC EPSILON RECEPTOR; FC RECEPTOR; HISTAMINE; INTERLEUKIN 2 RECEPTOR GAMMA; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; TRYPTASE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW BIOPSY; CANCER CELL CULTURE; CANCER PATIENT; CAPPING PHENOMENON; CASE REPORT; CELL ACTIVATION; CELL STRAIN LAD1; CELL STRAIN LAD2; CELL ULTRASTRUCTURE; CODON; CONTROLLED STUDY; CYTOLOGY; ENZYME RELEASE; GENE MUTATION; HUMAN; HUMAN CELL; MAST CELL; MAST CELL LEUKEMIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARCOMA; STRUCTURE ANALYSIS;

EID: 0037939677     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00343-0     Document Type: Article

References (14)

1. Butterfield J.H., Weiler D., Dewald G., Gleich G.J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:1988;345-355.
2. Nilsson G., Blom T., Kusche-Gullberg M., Kjellen L., Butterfield J.H., Sundstrom C.et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39:1994;489-498.
3. Fine H.F., Akin C., Hematti P., Butman J., Caruso R.C., Csaky K.G.et al. Presumed choroidal and orbital mastocytosis. Arch. Ophthalmol. 119:2001;1716-1719.
4. +, c-kit+, and expresses aminopeptidase N (CD13). Blood. 94:1999;2333-2342.
5. Prussin C., Metcalfe D.D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods. 182:1995;117-128.
6. Okayama Y., Kirshenbaum A.S., Metcalfe D.D. Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ J. Immunol. 164:2000;4332-4339.
7. Woolhiser M.R., Okayama Y., Gilfillan A.M., Metcalfe D.D. IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γ Eur. J. Immunol. 31:2001;3298-3307.
8. Akin C., Kirshenbaum A.S., Semere T., Worobec A.S., Scott L.M., Metcalfe D.D. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp. Hematol. 28:2000;140-147.
9. Akin C, Brockow C, D'Ambrosio C, Ma Y, Longley BJ, Metcalfe DD. Effects of the tyrosine kinase inhibitor STI571 on neoplastic human mast cells, submitted for publication.
10. + cells: comparisons with tumor mast-cell lines. Immunology. 66:2001;6647-6656.
11. + bone marrow progenitor cells. J. Immunol. 146:1991;1410-1415.
12. Valent P., Spanblochl E., Sperr W.R., Sillaber C., Zsebo K.M., Agis H.et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 80:1992;2237-2245.
13. Nilsson G., Forsberg K., Bodger M.P., Ashman L.K., Zsebo K.M., Ishizaka T.et al. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells. Immunology. 79:1993;325-330.
14. Longley B.J., Metcalfe D.D., Tharp M., Wang X., Tyrrell L., Lu S.Z.et al. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1609-1614.